Article Details

Science 37 taps a SPAC to go public, with siteless trial specialist valued at a cool $1B

Retrieved on: 2021-05-07 12:00:00

Tags for this article:

Click the tags to see associated articles and topics

Science 37 taps a SPAC to go public, with siteless trial specialist valued at a cool $1B. View article details on HISWAI: https://www.fiercebiotech.com/cro/science-37-taps-a-spac-to-go-public-siteless-trial-specialist-valued-at-a-cool-1b

Excerpt

... Capital (Novartis Pharma); LifeSci Venture Partners; Lux Capital; Mubadala Capital, the asset management arm of Mubadala Investment Company; ...

Article found on: www.fiercebiotech.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up